KPV

KPV is a tripeptide (Lysine-Proline-Valine) derived from the C-terminal end of alpha-melanocyte stimulating hormone (α-MSH). Despite being only three amino acids long, KPV retains the powerful anti-inflammatory properties of the full α-MSH molecule while being small enough for oral bioavailability. KPV has gained significant attention in the health optimization community for its gut-healing properties. It works by inhibiting inflammatory signaling pathways, particularly NF-κB, which is a master regulator of inflammation.

Studies have shown that KPV can reduce intestinal inflammation, protect against colitis, and modulate the gut microbiome. It also demonstrates antimicrobial activity against various pathogens including Staphylococcus aureus and Candida albicans. KPV can be administered via injection, orally, or even topically for skin conditions. Its oral bioavailability makes it particularly convenient for gut-related applications, as it can act directly on the intestinal mucosa.